Global Oncolytic Virus Immunotherapy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

September 2018 | 123 pages | ID: G10C0DD83A7EN
GlobalInfoResearch

Abstracts

Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).

Scope of the Report:

This report studies the Oncolytic Virus Immunotherapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oncolytic Virus Immunotherapy market by product type and applications/end industries.

North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.

The global Oncolytic Virus Immunotherapy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oncolytic Virus Immunotherapy.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Merck
• Amgen
• TILT Biotherapeutics
• Oncorus
• Sorrento Therapeutics
• Shanghai Sunway Biotech

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers

• Engineering Oncolytic Viruses
• Wild-Type Oncolytic Viruses

Market Segment by Applications, can be divided into

• Hospitals
• Clinics
• Ambulatory Surgical Centers
  
  

Contents

1 ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of Oncolytic Virus Immunotherapy
1.2 Classification of Oncolytic Virus Immunotherapy by Types
  1.2.1 Global Oncolytic Virus Immunotherapy Revenue Comparison by Types (2017-2023)
  1.2.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Types in 2017
  1.2.3 Engineering Oncolytic Viruses
  1.2.4 Wild-Type Oncolytic Viruses
1.3 Global Oncolytic Virus Immunotherapy Market by Application
  1.3.1 Global Oncolytic Virus Immunotherapy Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Ambulatory Surgical Centers
1.4 Global Oncolytic Virus Immunotherapy Market by Regions
  1.4.1 Global Oncolytic Virus Immunotherapy Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncolytic Virus Immunotherapy Status and Prospect (2013-2023)
1.5 Global Market Size of Oncolytic Virus Immunotherapy (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Merck
  2.1.1 Business Overview
  2.1.2 Oncolytic Virus Immunotherapy Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Merck Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
  2.2.1 Business Overview
  2.2.2 Oncolytic Virus Immunotherapy Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Amgen Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
2.3 TILT Biotherapeutics
  2.3.1 Business Overview
  2.3.2 Oncolytic Virus Immunotherapy Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Oncorus
  2.4.1 Business Overview
  2.4.2 Oncolytic Virus Immunotherapy Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Oncorus Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sorrento Therapeutics
  2.5.1 Business Overview
  2.5.2 Oncolytic Virus Immunotherapy Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
2.6 Shanghai Sunway Biotech
  2.6.1 Business Overview
  2.6.2 Oncolytic Virus Immunotherapy Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET COMPETITION, BY PLAYERS

3.1 Global Oncolytic Virus Immunotherapy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Oncolytic Virus Immunotherapy Players Market Share
  3.2.2 Top 10 Oncolytic Virus Immunotherapy Players Market Share
3.3 Market Competition Trend

4 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET SIZE BY REGIONS

4.1 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Regions
4.2 North America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
4.3 Europe Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
4.5 South America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA ONCOLYTIC VIRUS IMMUNOTHERAPY REVENUE BY COUNTRIES

5.1 North America Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)
5.2 USA Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
5.3 Canada Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
5.4 Mexico Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

6 EUROPE ONCOLYTIC VIRUS IMMUNOTHERAPY REVENUE BY COUNTRIES

6.1 Europe Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)
6.2 Germany Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
6.3 UK Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
6.4 France Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
6.5 Russia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
6.6 Italy Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC ONCOLYTIC VIRUS IMMUNOTHERAPY REVENUE BY COUNTRIES

7.1 Asia-Pacific Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)
7.2 China Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
7.3 Japan Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
7.4 Korea Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
7.5 India Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA ONCOLYTIC VIRUS IMMUNOTHERAPY REVENUE BY COUNTRIES

8.1 South America Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)
8.2 Brazil Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
8.3 Argentina Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
8.4 Colombia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE ONCOLYTIC VIRUS IMMUNOTHERAPY BY COUNTRIES

9.1 Middle East and Africa Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
9.3 UAE Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
9.4 Egypt Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
9.6 South Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)

10 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET SEGMENT BY TYPE

10.1 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Type (2013-2018)
10.2 Global Oncolytic Virus Immunotherapy Market Forecast by Type (2018-2023)
10.3 Engineering Oncolytic Viruses Revenue Growth Rate (2013-2023)
10.4 Wild-Type Oncolytic Viruses Revenue Growth Rate (2013-2023)

11 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET SEGMENT BY APPLICATION

11.1 Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2013-2018)
11.2 Oncolytic Virus Immunotherapy Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Ambulatory Surgical Centers Revenue Growth (2013-2018)

12 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET SIZE FORECAST (2018-2023)

12.1 Global Oncolytic Virus Immunotherapy Market Size Forecast (2018-2023)
12.2 Global Oncolytic Virus Immunotherapy Market Forecast by Regions (2018-2023)
12.3 North America Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
12.4 Europe Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
12.6 South America Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Oncolytic Virus Immunotherapy Picture
Table Product Specifications of Oncolytic Virus Immunotherapy
Table Global Oncolytic Virus Immunotherapy and Revenue (Million USD) Market Split by Product Type
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share by Types in 2017
Figure Engineering Oncolytic Viruses Picture
Figure Wild-Type Oncolytic Viruses Picture
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Application (2013-2023)
Figure Oncolytic Virus Immunotherapy Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Ambulatory Surgical Centers Picture
Table Global Market Oncolytic Virus Immunotherapy Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (2013-2023)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Oncolytic Virus Immunotherapy Type and Applications
Table Merck Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Oncolytic Virus Immunotherapy Type and Applications
Table Amgen Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
Table TILT Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table TILT Biotherapeutics Oncolytic Virus Immunotherapy Type and Applications
Table TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
Table Oncorus Basic Information, Manufacturing Base and Competitors
Table Oncorus Oncolytic Virus Immunotherapy Type and Applications
Table Oncorus Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
Table Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors
Table Sorrento Therapeutics Oncolytic Virus Immunotherapy Type and Applications
Table Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
Table Shanghai Sunway Biotech Basic Information, Manufacturing Base and Competitors
Table Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Type and Applications
Table Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue, Gross Margin and Market Share (2016-2017)
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Players (2013-2018)
Table Global Oncolytic Virus Immunotherapy Revenue Share by Players (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Players in 2016
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Players in 2017
Figure Global Top 5 Players Oncolytic Virus Immunotherapy Revenue Market Share in 2017
Figure Global Top 10 Players Oncolytic Virus Immunotherapy Revenue Market Share in 2017
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Regions (2013-2018)
Table Global Oncolytic Virus Immunotherapy Revenue Market Share by Regions (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share by Regions (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share by Regions in 2017
Figure North America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Europe Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure South America Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Table North America Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)
Table North America Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure North America Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure North America Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2017
Figure USA Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Canada Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Mexico Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Table Europe Oncolytic Virus Immunotherapy Revenue (Million USD) by Countries (2013-2018)
Figure Europe Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure Europe Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2017
Figure Germany Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure UK Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure France Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Russia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Italy Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Oncolytic Virus Immunotherapy Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2017
Figure China Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Japan Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Korea Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure India Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Table South America Oncolytic Virus Immunotherapy Revenue by Countries (2013-2018)
Table South America Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure South America Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure South America Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2017
Figure Brazil Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Argentina Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Colombia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Oncolytic Virus Immunotherapy Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Share by Countries in 2017
Figure Saudi Arabia Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure UAE Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Egypt Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure Nigeria Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Figure South Africa Oncolytic Virus Immunotherapy Revenue and Growth Rate (2013-2018)
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Type (2013-2018)
Table Global Oncolytic Virus Immunotherapy Revenue Share by Type (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Type (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Type in 2017
Table Global Oncolytic Virus Immunotherapy Revenue Forecast by Type (2018-2023)
Figure Global Oncolytic Virus Immunotherapy Market Share Forecast by Type (2018-2023)
Figure Global Engineering Oncolytic Viruses Revenue Growth Rate (2013-2018)
Figure Global Wild-Type Oncolytic Viruses Revenue Growth Rate (2013-2018)
Table Global Oncolytic Virus Immunotherapy Revenue by Application (2013-2018)
Table Global Oncolytic Virus Immunotherapy Revenue Share by Application (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Application (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue Share by Application in 2017
Table Global Oncolytic Virus Immunotherapy Revenue Forecast by Application (2018-2023)
Figure Global Oncolytic Virus Immunotherapy Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
Figure Europe Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
Figure South America Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Revenue Market Forecast (2018-2023)